Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
about
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Metformin use and cervical cancer risk in female patients with type 2 diabetesThe effect and mechanism of action of metformin on in vitro FaDu cell proliferation.Metformin affects thyroid function in male rats.Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain.Metformin targets Mitochondrial Glycerophosphate Dehydrogenase (mGPDH) to control Rate of Oxidative Phosphorylation and growth of thyroid cancer in vitro and in vivo.
P2860
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@en
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@nl
type
label
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@en
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@nl
prefLabel
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@en
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
@nl
P2093
P2860
P356
P1433
P1476
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
@en
P2093
Jeongwon Park
Keisuke Enomoto
Mark Willingham
Sheue-Yann Cheng
P2860
P304
34832-34844
P356
10.18632/ONCOTARGET.8989
P407
P50
P577
2016-06-01T00:00:00Z